Ngā hua rapu - Xin‐Ran Tang

  • E whakaatu ana i te 1 - 12 hua o te 12
Whakamahine hua
  1. 1
    Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma

    Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma mā Ying‐Qin Li, Xin-Ran Tang, Qing‐Mei He, Xiaojing Yang, Xianyue Ren, Xin Wen, Jian Zhang, Yaqin Wang, Na Liu, Jun Ma

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma

    MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma mā Xin-Ran Tang, Xin Wen, Qing-Mei He, Ying-Qin Li, Xianyue Ren, Xiao-Jing Yang, Jian Zhang, Yaqin Wang, Jun Ma, Na Liu

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways

    miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways mā Qing‐Mei He, Xianyue Ren, Jiewei Chen, Ying‐Qin Li, Xin-Ran Tang, Xin Wen, Xiaojing Yang, Jian Zhang, Yaqin Wang, Jun Ma, Na Liu

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway

    YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway mā Jiän Zhang, Xin Wen, Xianyue Ren, Ying-Qin Li, Xin-Ran Tang, Yaqin Wang, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Na Liu, Jun Ma

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma

    EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma mā Ying‐Qin Li, Qing‐Mei He, Xin Wen, Xiao-Hong Hong, Xiaojing Yang, Xin-Ran Tang, Panpan Zhang, Lei Yuan, Ying Sun, Jiän Zhang, Yaqin Wang, Jun Ma, Na Liu

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Hypermethylation of <i>SHISA3</i> Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability

    Hypermethylation of <i>SHISA3</i> Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability mā Jiän Zhang, Ying-Qin Li, Rui Guo, Yaqin Wang, Panpan Zhang, Xin-Ran Tang, Xin Wen, Xiao-Hong Hong, Lei Yuan, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Jun Ma, Na Liu

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma

    HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma mā Xianyue Ren, Xiaojing Yang, Bin Cheng, Xiaozhong Chen, Tianpeng Zhang, Qing‐Mei He, Bin Li, Ying‐Qin Li, Xin-Ran Tang, Xin Wen, Qian Zhong, Tiebang Kang, Mu‐Sheng Zeng, Na Liu, Jun Ma

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

    Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer mā Li Liu, Xue Bai, Jian Wang, Xin-Ran Tang, Dehua Wu, Shasha Du, Xiuju Du, Yaowei Zhang, Hongbo Zhu, Yuan Fang, Ze-Qin Guo, Qin Zeng, Xue‐Jun Guo, Zhu Liu, Zhong‐Yi Dong

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

    Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study mā Xue Bai, Dehua Wu, Si-Cong Ma, Jian Wang, Xin-Ran Tang, Shuai Kang, Qiang Fu, Chuanhui Cao, He-San Luo, Yuhan Chen, Hongbo Zhu, Hong‐Hong Yan, Yi‐Long Wu, Zhong‐Yi Dong

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy

    CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy mā Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Lijuan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang, Xin-Ran Tang, Yujie Zeng, Xinghua Pan, Dehua Wu, Zhong‐Yi Dong

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study

    Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study mā Yaqin Wang, Yu‐Pei Chen, Yu Zhang, Wei Jiang, Na Liu, Jing‐Ping Yun, Ying Sun, Qing‐Mei He, Xin‐Ran Tang, Xin Wen, Xiaojing Yang, Panpan Zhang, Jian Zhang, Lei Yuan, Ying‐Qin Li, Jun Ma

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study

    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study mā Wei Xu, Keshu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Kaiyang Ding, Jianfeng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jianda Hu, Chunyan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xin‐Ran Tang, Bin Zhang, Jianyong Li

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: